Management of Preterm Labor

 MANAGEMENT OF PRETERM LABOR

 

The purpose in treating preterm labor is to delay delivery, if possible, until fetal maturity is attained.

 

Management involves two broad goals: (1) the detection and treatment of disorders associated with preterm labor, and (2) therapy for the preterm labor itself. Fortunately,more than 50% of patients with preterm contractions have spontaneous resolution of abnormal uterine activity. However,this complicates the evaluation of effectiveness of specific treatments, because it is unclear if the contractions would have resolved spontaneously or if their cessation was due to effective treatments.

 

Various tocolytic therapies have been used in the management of preterm labor (Table 20.1). Tocolytics have not been shown to prolong pregnancy beyond sev-eral days (only 2 to 7). Different treatment regimens ad-dress specific mechanisms involved in the maintenance of uterine contractions, and each, therefore, may be best suited for certain patients.


Typically, patients with a diagnosis of preterm labor receive one form of tocolytic therapy, with the addition or substitu-tion of other medications if the initial treatment is considered unsuccessful.

 

Magnesium sulfate has been the most frequently used agent, but use of nifedipine is increasing. Evidence as to ef-ficacy beyond several days is weak, but often management allows for administration of corticosteroid therapy. Adverse side effects, at times serious and even life-threatening to the mother, can occur. The gestational age of the fetus is always a consideration in deciding how vigorously to pur-sue therapy. For example, maternal risks may be more ac-ceptable when treating a 26-week fetus as compared to a 32-week fetus.

 

Contraindications to tocolysis include conditions in which the adverse effects of tocolysis may be significant, such as advanced labor, a mature fetus, a severely anom-alous fetus (from lethal congenital or chromosomal abnormalities), intrauterine infection, significant vaginal bleed-ing, and severe preeclampsia. 

 

In addition, a variety of obstetric complications, such as placental abruption, ad-vanced cervical dilatation, or evidence of fetal compro-mise or placental insufficiency, may contraindicate delay in delivery.

 

From 24 to 32 to 34 weeks of gestation, management generally includes administration of corticosteroids (be-tamethasone or dexamethasone) to enhance fetal pul-monary maturity. A single course of corticosteroids should begiven to pregnant women between 24 and 32 weeks of gestation who are at risk of preterm delivery. Both the incidence andseverity of fetal respiratory distress syndrome are reduced with such therapy. Between 32 and 34 weeks of gestation,the use of steroids to enhance fetal lung maturity is less certain. In addition, other sequelae of prematurity, such as interventricular hemorrhage and necrotizing enterocoli-tis, occur less frequently in infants whose mothers re-ceived corticosteroid therapy. Maximal benefit to the fetus occurs if the therapy is administered within 7 days of de-livery; however, routine weekly courses are not recom-mended because of potential negative fetal effects.

Comments

Post a Comment

Popular posts from this blog

Major Causes of Postpartum Hemorrhage and their Management

Image
  MAJOR CAUSES OF POSTPARTUM HEMORRHAGE AND THEIR MANAGEMENT   Uterine Atony   Ordinarily, the uterine corpus contracts promptly after delivery of the placenta, constricting the spiral arteries in the newly created placental bed, and preventing excessive bleeding. This muscular contraction, rather than coagu-lation, prevents excessive bleeding from the placental implantation site. When contraction does not occur as expected, the resulting  uterine atony  leads to PPH. Conditions that predispose to uterine atony include those in which there is extraordinary enlargement of the uterus (such as polyhydramnios or twins); abnormal labor (both precipitous and prolonged, or augmented by oxy-tocin); and conditions that interfere with contraction of the uterus (such as uterine leiomyomata or magnesium sulfate). The clinical diagnosis of atony is based largely on the tone of the uterine muscle on palpation. Instead of the normally firm, contracted uterine corpus, a softer, more pliable— often cal
Read more

Cardiac Disease during pregnancy

Image
  CARDIAC DISEASE   With earlier diagnoses and more effective treatments, more women with congenital and acquired heart disease reach adulthood and may become pregnant. Patients with rheumatic heart disease (caused by untreated or delayed treatment of group A–hemolytic streptococcal [GAS] ton-sillopharyngitis) and acquired infectious valvular heart dis-ease (often associated with drug use) comprise only 50% of pregnant cardiac patients. The remainder consists of other cardiac conditions that traditionally have been less commonly seen in pregnancy.  Because pregnancy is itselfassociated with an increase in cardiac output of 40%, the risks to mother and fetus are often profound for women with pre-existing cardiac disease.  Ideally, cardiac patients should havepreconceptional care directed at maximizing cardiac func-tion. They should also be counseled about the risks their particular heart disease poses in pregnancy.   Classification of Heart Diseases in Pregnancy   The classification of
Read more

The Decision For Sterilization

Image
  THE DECISION FOR STERILIZATION   The decision for sterilization is an important one and the patient should be fully informed about the procedure and its risks, effectiveness, and long-term implications (Box 25.1). Components of presterilization counseling should include:   ·    Permanent nature of the procedure   ·    Alternative methods available, including male sterilization   ·    Reasons for choosing sterilization   ·    Screening for risk indicators for regret   ·    Details of the procedure, including risks and benefits   ·    The possibility of failure, including ectopic pregnancy   ·    The need to use condoms for protection against sexu-ally transmitted diseases, including HIV   ·    Completion of informed consent process   ·    Local regulations regarding interval from time of con-sent to procedure     Despite careful counseling, approximately 10% to 15% of patients who undergo sterilization subsequently report regret, although only 1% actually request reversal of the proce
Read more